Global Children Influenza Vaccine Market Research Report 2023

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The global Children Influenza Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Children Influenza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Children Influenza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Children Influenza Vaccine include Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Children Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Influenza Vaccine.

The Children Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Children Influenza Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Children Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Children Influenza Vaccine

1.2 Children Influenza Vaccine Segment by Type

1.2.1 Global Children Influenza Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Nasal Spray

1.2.3 Injection

1.3 Children Influenza Vaccine Segment by Application

1.3.1 Global Children Influenza Vaccine Market Value by Application: (2023-2029)

1.3.2 6 Months to 3 Years

1.3.3 Over 3 Years

1.4 Global Children Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Children Influenza Vaccine Revenue 2018-2029

1.4.2 Global Children Influenza Vaccine Sales 2018-2029

1.4.3 Global Children Influenza Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Children Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Children Influenza Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Children Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application

2.7 Children Influenza Vaccine Market Competitive Situation and Trends

2.7.1 Children Influenza Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Children Influenza Vaccine Players Market Share by Revenue

2.7.3 Global Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Children Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Children Influenza Vaccine Global Children Influenza Vaccine Sales by Region: 2018-2029

3.2.1 Global Children Influenza Vaccine Sales by Region: 2018-2023

3.2.2 Global Children Influenza Vaccine Sales by Region: 2024-2029

3.3 Global Children Influenza Vaccine Global Children Influenza Vaccine Revenue by Region: 2018-2029

3.3.1 Global Children Influenza Vaccine Revenue by Region: 2018-2023

3.3.2 Global Children Influenza Vaccine Revenue by Region: 2024-2029

3.4 North America Children Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Children Influenza Vaccine Sales by Country (2018-2029)

3.4.3 North America Children Influenza Vaccine Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Children Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Children Influenza Vaccine Sales by Country (2018-2029)

3.5.3 Europe Children Influenza Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Children Influenza Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Children Influenza Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Children Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Children Influenza Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Children Influenza Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Children Influenza Vaccine Sales by Type (2018-2029)

4.1.1 Global Children Influenza Vaccine Sales by Type (2018-2023)

4.1.2 Global Children Influenza Vaccine Sales by Type (2024-2029)

4.1.3 Global Children Influenza Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Children Influenza Vaccine Revenue by Type (2018-2029)

4.2.1 Global Children Influenza Vaccine Revenue by Type (2018-2023)

4.2.2 Global Children Influenza Vaccine Revenue by Type (2024-2029)

4.2.3 Global Children Influenza Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Children Influenza Vaccine Price by Type (2018-2029)

5.1 Global Children Influenza Vaccine Sales by Application (2018-2029)

5.1.1 Global Children Influenza Vaccine Sales by Application (2018-2023)

5.1.2 Global Children Influenza Vaccine Sales by Application (2024-2029)

5.1.3 Global Children Influenza Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Children Influenza Vaccine Revenue by Application (2018-2029)

5.2.1 Global Children Influenza Vaccine Revenue by Application (2018-2023)

5.2.2 Global Children Influenza Vaccine Revenue by Application (2024-2029)

5.2.3 Global Children Influenza Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Children Influenza Vaccine Price by Application (2018-2029)

6.1 Sanofi Pasteur

6.1.1 Sanofi Pasteur Corporation Information

6.1.2 Sanofi Pasteur Description and Business Overview

6.1.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio

6.1.5 Sanofi Pasteur Recent Developments/Updates

6.2 CSL

6.2.1 CSL Corporation Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 CSL Children Influenza Vaccine Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 GSK Children Influenza Vaccine Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Corporation Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Mylan Children Influenza Vaccine Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 Hulan Bio

6.5.1 Hulan Bio Corporation Information

6.5.2 Hulan Bio Description and Business Overview

6.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Hulan Bio Children Influenza Vaccine Product Portfolio

6.5.5 Hulan Bio Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 AstraZeneca Children Influenza Vaccine Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 CCBIO

6.6.1 CCBIO Corporation Information

6.6.2 CCBIO Description and Business Overview

6.6.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 CCBIO Children Influenza Vaccine Product Portfolio

6.7.5 CCBIO Recent Developments/Updates

7.1 Children Influenza Vaccine Industry Chain Analysis

7.2 Children Influenza Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Children Influenza Vaccine Production Mode & Process

7.4 Children Influenza Vaccine Sales and Marketing

7.4.1 Children Influenza Vaccine Sales Channels

7.4.2 Children Influenza Vaccine Distributors

7.5 Children Influenza Vaccine Customers

8.1 Children Influenza Vaccine Industry Trends

8.2 Children Influenza Vaccine Market Drivers

8.3 Children Influenza Vaccine Market Challenges

8.4 Children Influenza Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Children Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Children Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Children Influenza Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Children Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Children Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Children Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Children Influenza Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Children Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Children Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Children Influenza Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Children Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Influenza Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Children Influenza Vaccine Sales by Region (2018-2023) & (K Units)

    Table 18. Global Children Influenza Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Children Influenza Vaccine Sales by Region (2024-2029) & (K Units)

    Table 20. Global Children Influenza Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Children Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Children Influenza Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Children Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Children Influenza Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)

    Table 27. North America Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)

    Table 28. North America Children Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Children Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Children Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Children Influenza Vaccine Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Children Influenza Vaccine Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Children Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Children Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Children Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Children Influenza Vaccine Sales (K Units) by Type (2018-2023)

    Table 51. Global Children Influenza Vaccine Sales (K Units) by Type (2024-2029)

    Table 52. Global Children Influenza Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Children Influenza Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Children Influenza Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Children Influenza Vaccine Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Children Influenza Vaccine Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Children Influenza Vaccine Sales (K Units) by Application (2018-2023)

    Table 61. Global Children Influenza Vaccine Sales (K Units) by Application (2024-2029)

    Table 62. Global Children Influenza Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Children Influenza Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Children Influenza Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Children Influenza Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Children Influenza Vaccine Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Children Influenza Vaccine Price (US$/Unit) by Application (2024-2029)

    Table 70. Sanofi Pasteur Corporation Information

    Table 71. Sanofi Pasteur Description and Business Overview

    Table 72. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Sanofi Pasteur Children Influenza Vaccine Product

    Table 74. Sanofi Pasteur Recent Developments/Updates

    Table 75. CSL Corporation Information

    Table 76. CSL Description and Business Overview

    Table 77. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. CSL Children Influenza Vaccine Product

    Table 79. CSL Recent Developments/Updates

    Table 80. GSK Corporation Information

    Table 81. GSK Description and Business Overview

    Table 82. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. GSK Children Influenza Vaccine Product

    Table 84. GSK Recent Developments/Updates

    Table 85. Mylan Corporation Information

    Table 86. Mylan Description and Business Overview

    Table 87. Mylan Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Mylan Children Influenza Vaccine Product

    Table 89. Mylan Recent Developments/Updates

    Table 90. Hulan Bio Corporation Information

    Table 91. Hulan Bio Description and Business Overview

    Table 92. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Hulan Bio Children Influenza Vaccine Product

    Table 94. Hulan Bio Recent Developments/Updates

    Table 95. AstraZeneca Corporation Information

    Table 96. AstraZeneca Description and Business Overview

    Table 97. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. AstraZeneca Children Influenza Vaccine Product

    Table 99. AstraZeneca Recent Developments/Updates

    Table 100. CCBIO Corporation Information

    Table 101. CCBIO Description and Business Overview

    Table 102. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. CCBIO Children Influenza Vaccine Product

    Table 104. CCBIO Recent Developments/Updates

    Table 105. Key Raw Materials Lists

    Table 106. Raw Materials Key Suppliers Lists

    Table 107. Children Influenza Vaccine Distributors List

    Table 108. Children Influenza Vaccine Customers List

    Table 109. Children Influenza Vaccine Market Trends

    Table 110. Children Influenza Vaccine Market Drivers

    Table 111. Children Influenza Vaccine Market Challenges

    Table 112. Children Influenza Vaccine Market Restraints

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Children Influenza Vaccine

    Figure 2. Global Children Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Children Influenza Vaccine Market Share by Type in 2022 & 2029

    Figure 4. Nasal Spray Product Picture

    Figure 5. Injection Product Picture

    Figure 6. Global Children Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Children Influenza Vaccine Market Share by Application in 2022 & 2029

    Figure 8. 6 Months to 3 Years

    Figure 9. Over 3 Years

    Figure 10. Global Children Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Children Influenza Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Children Influenza Vaccine Sales (2018-2029) & (K Units)

    Figure 13. Global Children Influenza Vaccine Average Price (US$/Unit) & (2018-2029)

    Figure 14. Children Influenza Vaccine Report Years Considered

    Figure 15. Children Influenza Vaccine Sales Share by Manufacturers in 2022

    Figure 16. Global Children Influenza Vaccine Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Children Influenza Vaccine Players: Market Share by Revenue in 2022

    Figure 18. Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Children Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 21. North America Children Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 22. United States Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Children Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 25. Europe Children Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Children Influenza Vaccine Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Children Influenza Vaccine Revenue Market Share by Region (2018-2029)

    Figure 33. China Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. China Taiwan Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Indonesia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Thailand Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Malaysia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Latin America Children Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 43. Latin America Children Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 44. Mexico Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Brazil Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Argentina Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 48. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 49. Turkey Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. UAE Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Global Sales Market Share of Children Influenza Vaccine by Type (2018-2029)

    Figure 53. Global Revenue Market Share of Children Influenza Vaccine by Type (2018-2029)

    Figure 54. Global Children Influenza Vaccine Price (US$/Unit) by Type (2018-2029)

    Figure 55. Global Sales Market Share of Children Influenza Vaccine by Application (2018-2029)

    Figure 56. Global Revenue Market Share of Children Influenza Vaccine by Application (2018-2029)

    Figure 57. Global Children Influenza Vaccine Price (US$/Unit) by Application (2018-2029)

    Figure 58. Children Influenza Vaccine Value Chain

    Figure 59. Children Influenza Vaccine Production Process

    Figure 60. Channels of Distribution (Direct Vs Distribution)

    Figure 61. Distributors Profiles

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed